Public signalCompany raiseAuto-indexed · Unverified
Autolus Therapeutics plc raised $200.0M
Autolus Therapeutics plc· London, UNITED KINGDOM· Other· Filed Feb 23, 2024
Autolus Therapeutics plc reported raising capital. Based in London, UNITED KINGDOM. First sale reported 2024-02-13. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$200.0M
Confidence90%
Raised
$200.0M
Investors
1
Jurisdiction
UNITED KINGDOM
On the record
- Location
- London, UNITED KINGDOM
- Sector
- Other
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $200.0M
- Target amount
- $200.0M
- Filing date
- Feb 23, 2024
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- UNITED KINGDOM
- Industry group
- Other
- Number of investors
- 1
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $200.0M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Brent Rice
Executive Officer
London, UNITED KINGDOM
Christian Itin
Director
London, UNITED KINGDOM
Christopher Vann
Executive Officer
London, UNITED KINGDOM
Cynthia Butitta
Director
London, UNITED KINGDOM
David Brochu
Executive Officer
London, UNITED KINGDOM
Edgar Braendle
Executive Officer
London, UNITED KINGDOM
Elisabeth Leiderman
Director
London, UNITED KINGDOM
John Berriman
Director
London, UNITED KINGDOM
John H. Johnson
Director
London, UNITED KINGDOM
Joseph Anderson
Director
London, UNITED KINGDOM
Linda Bain
Director
London, UNITED KINGDOM
Martin Murphy
Director
London, UNITED KINGDOM
Martin Pule
Executive Officer
London, UNITED KINGDOM
Robert Azelby
Director
London, UNITED KINGDOM
Robert Dolski
Executive Officer
London, UNITED KINGDOM
Robert Iannone
Director
London, UNITED KINGDOM
William D. Young
Director
London, UNITED KINGDOM
Sources & provenance
“Operating company sold 200,000,000 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Feb 23, 2024. Details beyond the filing have not been verified.
Tags
UNITED-KINGDOMCompanyOtherOver $100MCompany Raise
Are you associated with Autolus Therapeutics plc?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record